Business Wire

Diligent Acquires Boardroom Resources to Power New Insights Content Module

Del

Diligent Corporation, the leader in enterprise governance management and the most trusted provider of secure board collaboration solutions, today announced the beta launch of Diligent Insights, a curated content feed of news and thought leadership resources developed exclusively for board directors. Serving more than 14,000 organizations and 450,000 users worldwide, Diligent continues to innovate and expand board governance tools and is excited to bring on more than 2,000 influential early adopter directors in the first wave of users on the Insights module — and is generating rave reviews.

Cyber risk oversight, shareholder activism and digital transformation — these are just some of the many pressing challenges confronting today’s board directors. To expand awareness and to spread knowledge of these issues in the boardroom, Diligent Insights delivers impactful articles and video content within the Diligent platform directly to board members.

Fueled by Diligent’s exciting recent acquisition of Boardroom Resources — the premier educational resource for board members — Insights provides reliable resources and third-party content contributed by trusted organizations such as the NACD, PwC’s Governance Insights Center and Spencer Stuart.

“The life of a board member can be fast-paced,” said T.K. Kerstetter, founder and CEO of Boardroom Resources and host of Inside America’s Boardrooms. “With Insights, Diligent is dedicated to arming directors with the guidance and resources necessary to navigate today’s fast-evolving landscape. This offering is just the first step in a very exciting multi-year roadmap of delivering thought leadership and best practices to the board, corporate secretary and general counsel.”

The Diligent Insights module empowers boards and governance professionals to lead with more confidence and to fulfill their board responsibilities with greater effectiveness. Insights users have the ability to customize their content feed by selecting the topics most relevant to their board, committees or areas of interest in order to both understand best practices and stay on top of timely issues related to their individual roles.

“As a director, it’s critical to have access to independent governance information. The content on Insights offers an impressive mix of articles, videos, research and oversight frameworks,” says Betsy Atkins, who currently serves on the boards of Cognizant, Schneider Electric, Volvo Cars and Wynn Resorts. “Because it sits right alongside my board materials, it’s easy to digest the content that’s most relevant to me and access it anytime from my Diligent iPhone app.”

Diligent thrives on empowering board members and enhancing their impact at each and every meeting — because in a world where business evolves with each passing second, Diligent knows that keeping board directors up to pace with the most relevant information has never been more crucial to staying ahead of the curve.

“Today, we’re constantly bombarded with information, but determining the best sources of content most relevant to you can be challenging,” says Diligent CEO Brian Stafford.

“That’s why we’ve created Diligent Insights — to provide board directors with the most insightful, highly curated content from widely acknowledged experts. With this latest addition to our Governance Cloud offering, we’re continuing to push the boundaries of innovation in the boardroom.”

Boards of directors can expect other exciting updates in the months ahead as Diligent continues to enhance its content offerings for boards. For more information on Insights and Diligent’s Governance Cloud, the only holistic enterprise governance management solution on the market, visit https://diligent.com and https://diligent.com/governance-cloud.

Contact information

Diligent Corporation
Greg Nyhan, 646-215-6884
gnyhan@mww.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CESTPressemelding

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 20:00:00 CESTPressemelding

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol